PARIS Feb 1 Sanofi /Regeneron :

* Sanofi and Regeneron Pharmaceuticals, Inc. in the present day introduced that Health Canada authorised Kevzara(TM)

* Product authorised for therapy of grownup sufferers with reasonably to severely lively rheumatoid arthritis (RA) who’ve had an insufficient response or intolerance to a number of biologic or non-biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs)

Source textual content on Eikon:





Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here